Arne Trummer

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Acute Lymphoblastic Leukemia

Rheumatoid Arthritis

Top Venues

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Lea Naomi Eder, Danilo Martinovic, Paolo Mazzeo, Christina Ganster, Justin Hasenkamp, Julia Thomson, Arne Trummer, Detlef Haase, Gerald Wulf
Fatal Progression of Mutated TP53-Associated Clonal Hematopoiesis following Anti-CD19 CAR-T Cell Therapy. Current oncology (Toronto, Ont.) 30 (1) (2023)
Lea Naomi Eder, Danilo Martinovic, Paolo Mazzeo, Christina Ganster, Justin Hasenkamp, Julia Thomson, Arne Trummer, Detlef Haase, Gerald Wulf
Fatal Progression of Mutated TP53-Associated Clonal Hematopoiesis following Anti-CD19 CAR-T Cell Therapy. Current oncology (Toronto, Ont.) 30 (1) (2023)
Lea Naomi Eder, Danilo Martinovic, Paolo Mazzeo, Christina Ganster, Justin Hasenkamp, Julia Thomson, Arne Trummer, Detlef Haase, Gerald Wulf
Fatal Progression of Mutated TP53-Associated Clonal Hematopoiesis following Anti-CD19 CAR-T Cell Therapy. Current oncology (Toronto, Ont.) 30 (1) (2023)
Lea Naomi Eder, Danilo Martinovic, Paolo Mazzeo, Christina Ganster, Justin Hasenkamp, Julia Thomson, Arne Trummer, Detlef Haase, Gerald Wulf
Fatal Progression of Mutated TP53-Associated Clonal Hematopoiesis following Anti-CD19 CAR-T Cell Therapy. Current oncology (Toronto, Ont.) 30 (1) (2023)
Lea Naomi Eder, Danilo Martinovic, Paolo Mazzeo, Christina Ganster, Justin Hasenkamp, Julia Thomson, Arne Trummer, Detlef Haase, Gerald Wulf
Fatal Progression of Mutated TP53-Associated Clonal Hematopoiesis following Anti-CD19 CAR-T Cell Therapy. Current oncology (Toronto, Ont.) 30 (1) (2023)
Lea Naomi Eder, Danilo Martinovic, Paolo Mazzeo, Christina Ganster, Justin Hasenkamp, Julia Thomson, Arne Trummer, Detlef Haase, Gerald Wulf
Fatal Progression of Mutated TP53-Associated Clonal Hematopoiesis following Anti-CD19 CAR-T Cell Therapy. Current oncology (Toronto, Ont.) 30 (1) (2023)